Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.
Saved in:
| Title: | Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits. |
|---|---|
| Authors: | Burci GL; Graduate Institute of International and Development Studies, Geneva, Switzerland., Gostin LO; O'Neill Institute for National and Global Health Law, Georgetown University, Washington, DC. |
| Source: | JAMA [JAMA] 2017 Feb 07; Vol. 317 (5), pp. 473-474. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28170485 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burci+GL%22">Burci GL</searchLink>; Graduate Institute of International and Development Studies, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gostin+LO%22">Gostin LO</searchLink>; O'Neill Institute for National and Global Health Law, Georgetown University, Washington, DC. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227501160%22">JAMA</searchLink> [JAMA] 2017 Feb 07; Vol. 317 (5), pp. 473-474. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7501160 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-3598 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200987484%22">00987484 </searchLink><i>NLM ISO Abbreviation: </i>JAMA <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28170485 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jama.2016.17994 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 473 Titles: – TitleFull: Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burci GL – PersonEntity: Name: NameFull: Gostin LO IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 02 Text: 2017 Feb 07 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1538-3598 Numbering: – Type: volume Value: 317 – Type: issue Value: 5 Titles: – TitleFull: JAMA Type: main |
| ResultId | 1 |